Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY booster comparison in adolescents previously primed with MenC vaccine
2010-022505-18Phase 2Completed
- Sponsor
- Health Protection Agency
- Start
- Dec 2011
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in meningococcal disease comparing Menveo with GSK MenACWY-TT conjugate vaccine (2 arms). Primary endpoint: Primary immunogenicity endpoint. Started Dec 2011; status: completed.
02
Drugs
meningococcal A conjugate vaccinemeningococcal conjugate vaccine GSK 134612
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2010-022505-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022505-18.